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ABSTRACT
This article summarises the significant lessons to be
drawn from, and the policy implications of, the findings of
the Methods of Assessing Response to Quality
Improvement Strategies (MARQuIS) project—a part of
the suite of research projects intended to support policy
established by the European Commission through its Sixth
Framework Programme. The article first reviews the
findings of MARQuIS and their implications for healthcare
providers (and particularly for hospitals), and then
addresses the broader policy implications for member
states of the European Union (EU) and for the commission
itself. Against the background of the European
Commission’s Seventh Framework Programme, it then
outlines a number of future areas for research to inform
policy and practice in quality and safety in Europe. The
article concludes that at this stage, a unique EU-wide
quality improvement system for hospitals does not seem
to be feasible or effective. Because of possible future
community action in this field, attention should focus on
the use of existing research on quality and safety
strategies in healthcare, with the aim of combining soft
measures to accelerate mutual learning. Concrete
measures should be considered only in areas for which
there is substantial evidence and effective implementation
can be ensured.
For the past decade, European policy makers have
been faced with a challenging contradiction. On
the one hand, healthcare remains fundamentally a
national responsibility of European Union (EU)
member states, outside the competences and
powers of the EU as set out in successive treaties.
This position is strongly defended by national
governments, which are understandably protective
of their healthcare systems. Yet on the other hand,
the rising tide of economic and social integration,
driven both by EU policies such as the single
market and by long-term societal trends in the
family, employment, education, language and
culture, have created increasing pressures for
convergence, coherence and coordination in health
system funding and provision. Since the European
Commission first established its high-level reflec-
tion process on patient mobility and healthcare
developments in 2003,1 and started the chain of
events that culminated in the recent publication of
a proposal for a directive on the application of
patients’ rights in cross-border care,2 it has been
increasingly clear that assuring the quality and
safety of healthcare is a central concern for all
stakeholders—the Commission itself, member
states, health system funding agencies, healthcare
providers, health professionals and patients. In
commissioning a number of research projects to
map, describe and analyse the quality of health-
care, and the policies and systems in place to assure
quality, the Commission provided an essential
evidence base for these policy developments, which
has undoubtedly been influential in shaping the
content of the current draft directive.3
This article summarises the significant lessons to
be drawn from, and policy implications of, the
findings of the Methods of Assessing Response to
Quality Improvement Strategies (MARQuIS) pro-
ject (box 1)—a part of the suite of research projects
intended to support policy research established by
the Commission through its Sixth Framework
Programme. This article first explores the lessons
for healthcare providers (and particularly for
hospitals), and then turns to analysing the lessons
and policy implications for EU member states and
for the Commission itself. Finally, it outlines a
number of future areas for research to inform
policy and practice in healthcare quality and safety
in Europe.
KEY FINDINGS FROM THE MARQuIS PROJECT AND
LESSONS FOR HOSPITALS
The MARQuIS project was designed to assess the
value of different quality strategies, and to provide
information on quality requirements for cross-
border patients. In addition, it aimed to provide
individual hospitals with information on the
development of their quality strategies.
Key findings of the study
Although the phenomena of cross-border care
(which can be broadly grouped into five categories:
temporary visitors abroad, people retiring as long-
term residents to other countries, people living in
border areas, people referred abroad for treatment,
and people who seek treatment abroad them-
selves)4 has received considerable policy attention,
our research confirmed that the overall phenom-
enon reflects only a small percentage of healthcare
service delivery (less then 1% of total hospital
admissions).5 In some regions and for some
hospitals, however, the volume of cross-border
care can be considerable, not only in terms of
hospitalisations but also for emergency visits. For
individual hospitals the issue of cross-border care
may therefore be highly relevant. Moreover, the
term cross-border patient itself can be confusing
because a person working for a local company, but
who is a citizen of another country, will not be
considered a cross-border patient, although the
expectations and needs of these patients may differ
from those of local patients. Our research provided
insight into the profile of cross-border patients,
most of whom seek care for acute conditions or for
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emergency care. For hospitalised cross-border patients, the most
frequent diagnoses involve the circulatory system or fractures.
In addition, deliveries and other diagnoses related to pregnancy,
pneumonia, appendicitis and other diseases of the digestive
system are common diagnoses for this population.5
Cross-border patients’ needs are similar to those of other
patients, but they have particular requirements that need to be
fulfilled to ensure quality healthcare and safety for these
patients.6 Information requirements with regard to the use of
different languages are more pronounced among cross-border
patients. Although hospitals use interpreters to improve
communication with these patients, our study shows that in
some cases it might be difficult for cross-border patients and
professionals to communicate at the same level and share
understanding during history taking, explanation of medica-
tions, and during discharge preparation. Moreover, informed
consent procedures differ considerably between countries in
terms of content and scope, which has practical implications
(relating, for example, to participation in clinical trials) and
raises potential legal issues related to the diversity of procedures.
Differences can also be identified in medical procedures (such as
the use of organs from non-heart patients, the scope of
rehabilitation services and caesarean section on demand), and
clinical practice guidelines may place emphasis on different
aspects across countries. Cross-border patients may also be
exposed to additional safety risks in view of prescription
procedures for drugs that differ in name and dosage between
countries, or in view of the difficulties of arranging medical
transport between countries.
With regard to the quality strategies employed by the
member states of the EU, the rate of progress varies
considerably.7 8 Although all countries implement the main
quality strategies to some extent (such as accreditation systems,
organisational quality management programmes, audit and
internal assessment of clinical standards, patient safety systems,
clinical practice guidelines, performance indicators and systems
for getting patient views), three groups of countries can be
identified. Countries where implementation is ‘‘well estab-
lished’’ have been active in the implementation of a wide range
of quality improvement strategies for years, and have well-
established systems in place. ‘‘Recent adaptors’’ have recently
established policies and strategies, and are in the process of
consolidating their regulatory systems. ‘‘Slow starters’’ have
begun initiatives in the field of quality improvement, but lack a
coherent programme of government policy in this area. Member
states belonging to the group of ‘‘recent adaptors’’ or ‘‘slow
starters’’ are thus advised to study the existing experience of
other member states with legislation in place, notably the
impact of statutory legal requirements, on the implementation
of quality improvement strategies in healthcare organisations.
Member states with well-developed systems, on the other hand,
could strengthen existing quality improvement legislation and
other regulatory instruments to enhance and spread effective
approaches to quality improvement.
Although research indicates some benefit of the regulatory
approaches to quality improvement, this classification should
not be confused with the implementation of quality improve-
ment strategies in hospitals belonging to a given country.
Analysis of the implementation of quality improvement
strategies in European hospitals reveals that hospitals with a
well-developed (and not so well-developed) quality improve-
ment system can be identified in all countries.9 10 The strategies
studied in MARQuIS are effective at the hospital level, although
the effect is nuanced depending on the level of analysis and the
outputs under consideration. External pressure appears to be
consistently associated with the implementation of quality
improvement strategies at the hospital level. The quality
improvement strategies under evaluation influence the imple-
mentation of different policies and procedures, and are, to
varying extents, associated with the attainment of hospital
output goals. Some of these associations, in particular with
regard to patient safety and patient-centredness, however, may
be confounded by hospital and country effects.11–13 Details of
these findings are discussed in other articles in this supplement.
While most of these results are relevant for EU member
states, some are also relevant for countries in other continents,
for example in North America, Asia, and Australia. With regard
to evaluating the effectiveness of quality improvement strate-
gies, similar research projects in the USA and Australia deserve
note,14 15 and the exchange of methodologies and findings may
accelerate research and quality improvement implementation in
the different settings. It should also be noted that other regions
provide cross-border care, for example between the USA and
Canadian border,16 and that some healthcare providers in Asia
market specialised healthcare services globally.17 In this context,
the results of our research on cross-border care may also inform
developments and quality improvement beyond the EU.
Limitations of the study
There are a number of limitations of the study, which are
discussed in detail in the different analyses presented elsewhere
in this supplement. However, some general limitations will be
addressed here. First, as in many other international studies on
quality and safety in healthcare, it should be noted that there
are substantial differences in the way member states organise
their health services, and ensure quality and safety of care, and
these differences pose substantial challenges to comparative
research.18 Moreover, the use of different languages and
terminology adds to this challenge. Although we made efforts
to reduce these biases (for example, by using protocols for
forward and backward translation in the design of the
questionnaires), certain imperfections in comparative research
on the organisation and impact of health services remain.
Second, the countries participating in the project are not
representative for all countries in the EU. Although efforts were
made to select hospitals randomly, the low response rates in
some countries limit the generalisability of the findings. Third,
the main outputs of the MARQuIS study are based on a cross-
sectional study design, since an experimental design would not
have been appropriate in light of the research questions. The
internal validity of the study is thus limited, and we cannot
establish causality for the findings. Lastly, due to logistic and
financial limitations we could not include clinical and patient-
reported outcome measures in this study.
Box 1: How the subject of this paper links to better patient
care
c The MARQuIS project is providing a comparative analysis on
the impact of different quality management strategies in EU
hospitals
c The results of the project are guiding the development of
quality improvement strategies in order to improve patient
care, and adding to the evidence base on the effectiveness of
quality management systems
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Nevertheless, it should be emphasised that theory and
knowledge regarding the impact of quality improvement
systems are at an early stage, and the MARQuIS project makes
important contributions to further developing the evidence base
in this field. Interestingly, researchers in Australia and the USA
are using similar strategies to evaluate the effectiveness of their
systems, to ensure the quality and safety of healthcare
services.19 20 In terms of assessing the external validity of the
results and the applicability of the recommendations, it should
be borne in mind that the findings are based on a substantial
sample of European hospitals. In addition, to ensure clarity and
feasibility of the full recommendations, a public consultation
exercise was carried out involving project partners, country
coordinators, members of the Advisory Council, the High Level
Group, the Working Group on Patient Safety, researchers and
selected European organisations. The results of the consultation
exercise showed that overall, most recommendations were
considered to be clear and feasible by the respondents.
Individual recommendations that obtained lower ratings in
terms of clarity or feasibility were revised. The full report on the
consultation process is available on the MARQuIS website.21
What can hospitals learn from MARQuIS to improve quality and
safety?
The implementation of strategies and policies to improve
healthcare quality and safety (such as systems for obtaining
patients’ views, performance indicators, patient safety systems,
clinical guidelines, accreditation schemes, audit or internal
assessment of clinical standards, and organisational quality
management programmes) may sometimes appear to be remote
from clinical practice, but they do have an impact on the
management of patients. Hospitals are thus encouraged to
devote sufficient resources to quality improvement infrastruc-
tures, information systems and professional training in quality
improvement. Although hospitals with a strong systematic
approach to quality improvement are more likely to implement
quality throughout the organisation, not all strategies in the
quality toolbox are equally effective in all settings, and a
combination of strategies appears to be more effective than a
focus on a single strategy. Moreover, quality strategies require
reinforcement at the clinical level to promote and adapt them to
the specific context, such as the department, disease group or
professional group.22
Structured guidelines may be developed or adapted within
hospitals to systematically provide crucial information related
to the administrative and clinical process for cross-border
patients. Because many cross-border patients may not under-
stand the language commonly used in a given setting, brochures
on hospital organisation and (clinical) information leaflets could
be translated into the language spoken by the most relevant
groups of cross-border patients. In addition, hospitals may want
to take stock of the languages spoken by their staff, and provide
interpreters as necessary, in particular, to ensure that patients
understand the information provided and can participate in
decisions (for example, procedures for informed consent or
shared clinical decision making). In order to ensure safety and
continuity of care, prescriptions at discharge should use generic
drug names, and should specify the dose of active component.
Furthermore, at discharge, cross-border patients should receive
enough medication to ensure continuity of treatment until the
next point of care. Few hospitals appear to make sufficient use
of patients’ knowledge. Most hospitals carry out periodic
surveys on patients’ views, but the learning experience from
these surveys is often not used to improve processes. Moreover,
patients or patient groups are rarely involved in the develop-
ment and evaluation of quality systems, although patients can
make valuable contributions in this area. With regard to
improving the quality and safety of cross-border care, hospitals
should be aware that the needs of cross-border patients are
similar to those of other patients, but that specific information
and communication requirements exist and which should be
promoted. The resource implications of these recommendations
need to be assessed by individual hospitals in view of the
volume of cross-border patients.
Although the emphasis on specific quality improvement
strategies differs between countries and hospitals, the
MARQuIS project, building on earlier EU-funded studies on
quality of hospital care (COMAC and Biomed I and II), has
again demonstrated the benefits of European research studies
involving large samples of hospitals in an active way. Feedback
from the hospitals on both the survey and the audit has been
positive, and this type of action-oriented research not only has
merits in producing new scientific knowledge, but also serves as
an external ‘‘European’’ incentive for hospitals to reflect on their
own experience, and compare themselves with colleagues. This
seems especially true for concrete comparisons at the depart-
mental level relating to specific clinical care processes. As such,
an additional lesson to be learned is that similar European
research projects should be more action based, thus enabling
participating hospitals to benefit from the experience and
enhance mutual learning.
POLICY IMPLICATIONS FOR THE EU AND ITS MEMBER STATES
The MARQuIS project provides a wide range of evidence which
should encourage both the European Commission and EU
member states to adopt formal policies and strategies designed
to assure and improve the quality of healthcare. In brief, at both
the national and at organisational level, our findings suggest
that these policies ‘‘work’’—that is, they contribute to bringing
about improvements in the quality of patient care. But beyond
that, there are a number of more specific and focused lessons
about both the direction of strategies or policies, and about their
implementation, which deserve to be highlighted.
Considerations at the level of EU member states
For EU member states, our findings do not suggest that there is
a single approach or methodology for safety and quality
measurement and improvement that should be adopted because
of being demonstrably more effective than others, or because it
is already predominant in use elsewhere. Rather, we found a
multitude of different, overlapping and sometimes duplicative
quality improvement initiatives, which often promoted, or
focused on, different aspects or dimensions of quality and
safety, and which were probably most effective when used in
combination. However, the acceptance, or even promotion, of
such multilateral and multifaceted strategies for quality
improvement may mean that greater attention needs to be
paid to their integration and internal consistency or coherence.
For individual member states it is clear that there is much to be
learned from the experiences of other member states in
establishing healthcare quality improvement systems, and an
opportunity to accelerate learning as well as progress signifi-
cantly. It seems that efforts to provide a strong statutory
framework for quality improvement should aim to embed
quality improvement within existing health system funding and
provision systems. This approach would provide resources to
support the creation of improvement capacities in health
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systems and healthcare organisations, and would ensure that
mechanisms exist to monitor implementation, follow up on
compliance, and evaluate impact—all of which are necessary
components of a strategy for healthcare quality improvement at
the national level.
Strategies to improve quality and safety (such as systems for
obtaining patients’ views, performance indicators, patient
safety systems, clinical guidelines, accreditation schemes, audit
or internal assessment of clinical standards, and organisational
quality management programmes) promote different aspects of
quality, and are most effective when used in combination.
Member states in the process of developing their quality
strategies are thus encouraged to study existing experiences,
notably the impact of statutory legal requirements on the
implementation of quality improvement strategies in healthcare
organisations. In addition, the effect of external assessment
programmes should be examined by countries that are devel-
oping their quality tools, given the effectiveness of such
programmes. Further aspects that should be promoted are
leadership, proper resource allocation, education and training,
and planning and evaluation of quality improvement activities.
Few hospitals currently provide opportunities for patient and
public involvement in designing hospital services, and member
states may want to address this with specific incentives.
In order to improve the quality and safety of cross-border
care, two particular issues could be promoted by member states.
First, professional criteria should determine eligibility for
elective treatment abroad, and administrative criteria should
evolve based on professional judgement. Second, member states
should provide incentives for financiers and healthcare providers
to collect data on long-term outcomes of cross-border services,
even if these data need to be collected in different countries.
Although not studied specifically in the MARQuIS project, EU
member states may wish to assess the availability and
requirements for quality improvement legislation beyond
hospital services, for example, in areas such as primary
healthcare, mental health, long-term care, and private health-
care provision.
Policy implications at the EU level
The lessons and policy implications for the EU and the
European Commission are perhaps more nuanced (box 2), and
their adoption must clearly take account of the Realpolitik of the
European institutions and stakeholders involved in shaping
health policy—a necessity well demonstrated by the difficulties
already encountered in framing the current draft directive on
cross-border care. The research can be taken to confirm that
greater coherence and convergence across and between member
states in both the quality and safety of healthcare, and in the
systems used to assure quality and safety, are at least desirable
and might even be considered essential. However, coherence
and convergence could be achieved either quickly through top-
down directive action at the European level or slowly through
bottom-up collaborative action between member states. The
latter seems a more realistic prospect, and so attention is likely
to turn to funding and promoting actions designed to support
such evolutionary and voluntary convergence, at least in the
short to medium term. However, as current initiatives in
healthcare quality and safety cooperation develop further, it will
become increasingly feasible at some point to contemplate the
adoption of a more formal, directive-based mechanism for
convergence in the future.
The EU may consider a number of steps to further advance
healthcare quality and safety actions in Europe. In many
member states, quality policies and strategies are developed by
multiple stakeholders at both subnational and regional levels as
well as at the state level. The EU may promote existing quality
mechanisms initiated by governments, hospital management,
healthcare financiers, professionals or patient and consumer
organisations by enhancing synergies between the activities of
various actors within and between countries. The EU may
further facilitate exchange of information on the impact of
existing external assessment programmes applied to hospitals.
Further attention may focus on assessing full implementation in
all EU member states of existing EU directives in the healthcare
field. With regard to cross-border care, improvements at the EU
level may be instigated by introducing consistent coding of
cross-border patients, and by using clinical and administrative
minimum data sets that include mandatory inter-country
equivalent fields (such as country of origin, diagnosis and
categories of cross-border care). The EU could further improve
the cross-border patient’s experience by assessing the feasibility
of specific actions, such as common content for informed
consent in EU countries, or a standardised European (electronic)
format for the discharge summary to improve communication
between providers and patients.
FUTURE DIRECTIONS FOR RESEARCH AND POLICY
The MARQuIS, Europe4Patients, and SYMPATIE projects have
among them established that timely, applied research has an
important part to play in informing and shaping EU policy on
quality safety.23 Looking forward, it is encouraging that the
European Commission’s Seventh Framework research pro-
gramme contains a number of actions and initiatives grouped
together as concerned with optimising the delivery of healthcare
to European citizens. Topics include the implementation of
research in clinical practice, patient safety in medication usage,
continuity of care, chronic disease management, long-term care
for the elderly, human resource planning, clinician working
times and safety, and health outcome measurement.24 Taken
together, this set of new research initiatives represents a
substantial investment of research resources in the creation of
new quality improvement techniques and methods, and will
Box 2: Should the EU support the development of unique
quality improvement systems, or instead help to
strengthen existing systems?
c EU member states have adapted a wide range of different
strategies to safeguard the quality and safety of hospital
services
c All these strategies appear to contribute to improving quality
and safety; however, there is as much variation within, as
there is between, countries in the extent to which hospitals
have implemented such strategies
c Convergence of improvement systems should thus be
promoted through the use of different strategies and
requirements identified at the national level
c At this stage, a unique quality improvement system for EU
member states may not be necessary or effective
c Nevertheless, further research should address how the
systematic implementation of quality improvement strategies
by hospitals in member states can be safeguarded
c Moreover, differences in the strategies applied should be made
more transparent for citizens and patients
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continue to build on the work already undertaken through the
Sixth Framework Programme.
However, the collaborative, bottom-up approach to policy
development which has been adopted may need to be matched
by a more collaborative and networked approach to research,
both by funding agencies and by researchers. Institutions such
as the International Society for Quality in Health Care, the
European Society for Quality in Health Care and the European
Health Management Association, and national-level health
research funding agencies, have a part in ensuring that the
growing investment in quality and safety research at the
national level is framed and used in ways that maximise
international transferability and value. For example, in the UK,
the National Institute for Health Research has just invested £10
million in founding two academic centres for research on
patient safety and service quality, and is about to invest about
£90 million in a series of academic centres for applied health
research, much of whose work will address issues of quality in
healthcare delivery. In the Netherlands over the past years, the
government has invested up to J100 million in a series of
national quality improvement and innovation programmes that
involve a substantial number of providers in hospital care, home
care, care for the elderly, nursing home care, mental health and
public health services. In many other European countries,
similar programmes or agencies exist or are being created, and
opportunities for learning and exchange between them need to
be sought and secured. In addition, in selected areas research
and collaboration might be complemented by Community
action.
At the EU health policy level a number of issues need to be
considered to balance feasibility and effectiveness in the
development of quality and safety strategies. The recent
publication of the proposal for a European Directive on the
application of patients’ rights in cross-border healthcare
emphasises that when healthcare is provided, it is vital for
patients to receive2
‘‘clear information that enables patients to make informed
choices about their health care, mechanisms for ensuring quality
and safety of the health care that is provided, continuity of care
between different treating professionals and organisations, and
mechanisms to ensure appropriate remedies and compensation
for harm arising from health care.’’
The proposal, based as it is on the common values and principles
in EU health systems,25 makes clear that the Directive does not
aim to interfere with existing health and social security systems,
nor to undermine the sovereignty of individual countries in
issuing legislation on quality and safety issues in healthcare.
Nevertheless, the fact that it is not possible to know in advance
which healthcare provider will supply cross-border care blurs
the distinction between quality improvement for cross-border
patients, on the one hand, and general quality improvement
efforts, on the other. Also, the interpretation of the common
values and principles by different EU member states may differ
and lead to different strategic choices as to how to ensure the
quality and safety of healthcare.26 This may lead to the need for
more European-wide cooperation in the field of quality improve-
ment in the future, particularly in (but not restricted to) the issues
identified in our research, namely, the implementation of effective
Key messages
c There are clear differences in the extent to which EU member states have formalised legislation and statutory requirements, and have
implemented strategies to improve the quality of care. Some member states have substantial experience in this field, whereas others are
just getting started. This does not mean, however, that hospitals in member states with a long history of legislation on quality
improvement have systematically adopted this experience
c Hospitals with a well-developed quality improvement system can be found in all member states, and there is as much variation in the
uptake of quality improvement strategies within countries as there is between countries
c Regarding the sovereignty of EU member states in the issues of healthcare legislation, at this stage a unique EU-wide quality
improvement system does not seem to be feasible, nor are there guarantees that such a system would be effective. This is reflected in
the current proposal for an EU directive on the application of patients’ rights in cross-border care, which affirms that member states
should ensure the quality and safety of healthcare based on the ‘‘common values and principles in European Union health systems’’
c Member states’ interpretation of these values and principles, however, may differ, and may lead to different rates of implementing quality
and safety strategies. Moreover, given that it is impossible to know in advance which healthcare providers will supply services to cross-
border patients in the future, these quality requirements should be extended to all healthcare facilities
c At the EU level, additional concrete measures may thus be introduced for specific quality requirements, as for example, in the field for
radiology, blood and tissues, for which EU directives already exist
c At the same time, voluntary initiatives can be supported to assess and improve the quality and safety of cross-border care driven by
institutions operating within specific cross-border agreements, or by those with a particular interest in attracting cross-border patients.
c Future action in this field should make use of the existing research on quality and safety strategies in healthcare, and should aim to
combine ‘‘soft’’ measures to accelerate mutual learning, and consider concrete measures only in areas for which a substantial evidence
base exists, and effective implementation is likely
Summary points for further research
c Support further research to develop and validate a
classification model for quality improvement systems in
hospitals
c Test associations of quality improvement systems and their
impact on outcome assessed in terms of safety, clinical
effectiveness and patients’ views
c Carry out a mapping exercise of existing organisational
standards and criteria of European quality improvement
systems
c Assess the implementation of current EU directives pertinent
to hospital services
c Analyse and monitor volume and type of cross-border care in
order to improve understanding of cross-border movement, its
impact on quality, and organisational and professional cultures
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quality and safety strategies to ensure that patients have access to
key medical, financial, and practical information, and to ensure
continuity of healthcare.
It is conceivable that in the future, additional concrete
measures may be introduced for specific quality requirements,
as is now the case in the fields of radiology, blood and tissues
and cells, for which EU directives exist.27–29 The introduction of
any concrete measures should be accompanied by supporting
implementation and evaluation strategies. Looking beyond the
policy debate, however, it should not be forgotten that ensuring
the same level of quality and safety among all healthcare
providers is desirable but unattainable, as demonstrated by
persistent variations in medical practice and outcomes within
member states and even within hospitals.30–32
CONCLUSION
The MARQuIS study has produced the first assessment of the
value of different quality strategies implemented across
hospitals in EU member states. A key result is that member
states and hospitals have implemented a range of different
quality improvement strategies which appear to be effective in
ensuring quality and safety. However, there is substantial
variation within and between countries in the extent to which
hospitals systematically implement these strategies.
In the context of cross-border care an important policy
implication of the study is that, given the effectiveness of these
strategies, it is not necessary at the EU level to develop a unique
quality improvement system. Moreover, considering the varia-
tion in maturity classification of hospitals within countries,
there is no reason to assume that strategy implementation at
the EU level will be more effective than current approaches put
forward by member states. On the other hand, the wide range
of strategies applied, and the variability of their implementa-
tion, offer unique opportunities for further learning and
exchange, which should be stimulated by the EU.
On the research side, the MARQuIS project provides new
insight into the little-studied topic of cross-border care, and may
help researchers to set the future research agenda. For quality
improvement researchers, the development of a quality
improvement classification system and the evaluation of its
impact on patient-centredness, patient safety and hospital
outputs offer new opportunities for comparative analyses of
quality improvement strategies. In the future, this may lead to
better knowledge of the effectiveness of quality improvement
strategies, which may in turn inform hospital managers,
purchasing agencies and regulators.
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